You successfully added to your cart! You can either continue shopping, or checkout now if you'd like.
Note: If you'd like to continue shopping, you can always access your cart from the icon at the upper-right of every page.
Sequential CQ / HCQ Research Papers and Reports
January to April 20, 2020
Executive Summary Interpretation of the Data In This Report
The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagious infectivity in most cases.
Comment: There are alternate drugs, some costing as much as $1000 for a single pill, which are competing with HCQ, which is now a generic drug and costs about 50 cents. Billions of dollars are at stake, so if you see articles advocating those other drugs, please understand the bias and payoffs to journalists to post these.
Also note that HCQ-AZ is said to be effective in reducing deaths of “elderly patients” down to a half percent. All other patients would have a far greater chance to survive.